Published

Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of Psychedelic Studies
Date: 2026-07-12
Source: Crossref
DOI: 10.1556/2054.2026.00505
PubMed: Unavailable

Authors

Hörnqvist Nils

Watch author

Derived topics and classifications

psilocybin Depression Review Article Observational Study Treatment-Resistant Depression Review Article

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1001/jamapsychiatry.2023.4685 10.1176/appi.ajp.20231063 10.1093/ijnp/pyaf023 10.1001/jamaoncol.2023.0351 10.1002/cncr.35010 10.1038/s41398-025-03556-4 10.1001/jamanetworkopen.2024.49026 10.1037/t00742-000 10.1017/s1092852900000389 10.1177/02698811251324372 10.1038/s41386-025-02097-0 10.1016/s2215-0366(16)30065-7

Indexed papers citing this DOI

Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview2026-07-12

Related papers

Is Psychedelic Medicine on the Horizon?Psychiatric News · 2019-02-27 Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.Science Advances · 2021-11-16 A biosynthetic sequence from tryptophan to psilocybin.Unknown journal · 1968-01-31 Biosynthesis of psilocybin. II. Incorporation of labelled tryptamine derivatives.Unknown journal · 1967-12-31